PSI Banner - General (950 x 300 px)

2026 Conference Sessions

Session presentations, where consent has been given to share, are available below. They are listed by date and session title in order of programme appearance, with slide decks available to download via the links. 
Please note: these are only accessible for PSI Members, and you will need to be signed in to access them.

Individual abstracts can also be found here: Individual Abstracts 2026

Posters can be found in the 2026 Poster Gallery.

Monday 15 June

Kimberley Hacquoil, Veramed
Frances Denny, MMS Holdings Europe Ltd
Sam Ruddell, Chiesi Ltd

Dose response (Career Young Speakers)

Isabelle Smith, Veramed
Sam Miller, MMS
Andy Grieve, Weatherden
Tim Friede, University Medical Center, Göttingen

Patient-Focused Drug Development SIG - Tolerability PROs across the drug development lifecycle

Direct research collaborations - David Wright, AstraZeneca & Dea Hazewinkel, London School of Hygiene & Tropical Medicine
PhD industry supervision - Tom Burnett, University of Bath, Ian Wadsworth, Phastar & Samuel Williams, University of Bath
Collaborating on grant applications - Michael Grayling, Johnson & Johnson & James Wason, Newcastle University

Lesedi Ledwaba-Chapman, MMS
Paola Berchialla, University of Torino
Harry Parr, GSK
Jason Nicholas, GSK

Stefanie Wüstner, AMS Advanced Medical Services GmbH
Anton Schönstein, Boehringer Ingelheim
Lena Stein, AMS Advanced Medical Services GmbH

Estimands: Uptake, application and communication

Tim Friede, University Medical Center, Göttingen
Sue Todd, University of Reading
Chrissie Fletcher, GSK
Elina Asikanius, FIMEA

Causal inference

Mixed (Career Young speakers)

Decision making

Tuesday 16 June



AI/Machine learning

Christopher Jennison, University of Bath
David Robertson, MRC Biostatistics Unit, University of Cambridge
Michael Grayling, Johnson and Johnson

Vaccines SIG - Innovative statistical approaches, designs and predictive models in vaccine clinical trials

Arthur Allignol, Daiichi Sankyo - PANELLIST

Randomisation SIG - Beyond chance: Randomisation designs for innovative clinical trials


Adaptive designs

Use of Open-source software

EFPIA Estimand Implementation Working Group - The estimand conundrum - is ICH E9 R1 crystal clear or are there still areas of confusion?

Addressing the challenges of small sample size in rare diseases

Complex trial design

Wednesday 17 June

Non-inferiority and equivalence comparisons in clinical trials
Chair: David Wright, AstraZeneca
Helle Lynggaard, Novo Nordisk
Florian Lasch, EMA
Use of external controls and real-world evidence to support regulatory decision making
Chair: Rima Izem, Novartis
Elina Asikanius, FIMEA
Khadija Rantell, MHRA

Bayesian modelling

On the interplay between prior weight and variance of the robustification component in robust mixture prior Bayesian dynamic borrowing approach - Marco Ratta, Saryga

RWD SIG - Real-world data – do you know all the opportunities? The key questions they can answer and how


Patient reported outcomes

Non-technical bitesize

Bayesian adaptive trial designs

Statistical innovations for efficient endpoint analysis: Beyond dichotomization

 

 

Upcoming Events

Latest Jobs